These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 9696434)

  • 41. [Influencing factors in the control of phosphorus in peritoneal dialysis. Therapeutic options].
    Gallar P; Ortega O; Gutiérrez M; Muñoz M; Hilara L; Oliet A; Rodríguez I; Giménez E; Vigil A
    Nefrologia; 2000; 20(4):355-61. PubMed ID: 11039261
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Clinical and analytical changes in hemodialysis without acetate].
    Coll E; Pérez-García R; Rodríguez-Benítez P; Ortega M; Martínez Miguel P; Jofré R; López-Gómez JM
    Nefrologia; 2007; 27(6):742-8. PubMed ID: 18336105
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Relationship between serum parathyroid hormone and trace elements (serum zinc and magnesium) in hemodialyzed chronic renal failure children.
    El Tayeb AA; Abd El-Mottaleb NA; Abdel Aziz EA
    Biol Trace Elem Res; 2009 May; 128(2):128-34. PubMed ID: 18972069
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Magnesium metabolism in chronic renal failure.
    Mountokalakis TD
    Magnes Res; 1990 Jun; 3(2):121-7. PubMed ID: 2133626
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis.
    Nasri H; Baradaran A; Naderi AS
    Acta Med Austriaca; 2004 Aug; 31(3):67-72. PubMed ID: 15515479
    [TBL] [Abstract][Full Text] [Related]  

  • 46. 2004 Japanese Society for Dialysis Therapy guidelines for renal anemia in chronic hemodialysis patients.
    Gejyo F; Saito A; Akizawa T; Akiba T; Sakai T; Suzuki M; Nishi S; Tsubakihara Y; Hirakata H; Bessho M;
    Ther Apher Dial; 2004 Dec; 8(6):443-59. PubMed ID: 15663544
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The association of lipid levels with mortality in patients on chronic peritoneal dialysis.
    Habib AN; Baird BC; Leypoldt JK; Cheung AK; Goldfarb-Rumyantzev AS
    Nephrol Dial Transplant; 2006 Oct; 21(10):2881-92. PubMed ID: 16735386
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Clinical importance of magnesium metabolism].
    Haldimann B
    Schweiz Med Wochenschr; 1982 Oct; 112(40):1366-8. PubMed ID: 7146852
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Continuous Observation of Serum Total Magnesium Level in Patients Undergoing Hemodialysis.
    Yang W; Wang E; Chen W; Chen C; Chen S
    Blood Purif; 2021; 50(2):196-204. PubMed ID: 32866952
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effect of hemodialysis on serum magnesium concentration in hemodialysis patients.
    Han Z; Zhou L; Liu R; Feng L
    Ann Palliat Med; 2020 May; 9(3):1134-1143. PubMed ID: 32498528
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Magnesium Balance in Chronic and End-Stage Kidney Disease.
    Oliveira B; Cunningham J; Walsh SB
    Adv Chronic Kidney Dis; 2018 May; 25(3):291-295. PubMed ID: 29793669
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Inadvertently high dialysate magnesium causing weakness and nausea in hemodialysis patients.
    Chakurkar VV; Gade PS; Godbole AV; Wadia FF; Lobo VA
    Hemodial Int; 2019 Oct; 23(4):E106-E110. PubMed ID: 31115142
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Serum Magnesium Abnormality and Influencing Factors of Serum Magnesium Level in Peritoneal Dialysis Patients: A Single-Center Study in Northern China.
    Tsai S; Zhao H; Wu B; Zuo L; Wang M
    Blood Purif; 2018; 45(1-3):110-117. PubMed ID: 29241212
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Magnesium status in chronically haemodialyzed patients: the role of dialysate magnesium concentration.
    Gonella M; Calabrese G
    Magnes Res; 1989 Dec; 2(4):259-65. PubMed ID: 2701862
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Beneficial effects of magnesium in chronic renal failure: a foe no longer.
    Tzanakis IP; Oreopoulos DG
    Int Urol Nephrol; 2009; 41(2):363-71. PubMed ID: 19115076
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Potassium metabolism in patients with chronic kidney disease. Part II: patients on dialysis (stage 5).
    Musso CG
    Int Urol Nephrol; 2004; 36(3):469-72. PubMed ID: 15783126
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Magnesium and the treatment by repeated hemodialysis].
    Aebischer N; Fellay G
    Rev Med Suisse Romande; 1982 Sep; 102(9):853-5. PubMed ID: 7146712
    [No Abstract]   [Full Text] [Related]  

  • 58. Dialysate Potassium, Dialysate Magnesium, and Hemodialysis Risk.
    Pun PH; Middleton JP
    J Am Soc Nephrol; 2017 Dec; 28(12):3441-3451. PubMed ID: 28993507
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Achilles tendon reflex time and electrolyte balance in kidney failure].
    Zumkley H; Guldner L
    Med Klin; 1970 Aug; 65(32):1441-4. PubMed ID: 5523874
    [No Abstract]   [Full Text] [Related]  

  • 60. Proceedings: Effect of magnesium on secondary hyperparathyroidism in chronic hemodialysis: a case with soft tissue calcification improved by high Mg dialysate.
    Izawa H; Imura M; Kuroda M; Takeda R
    Calcif Tissue Res; 1974; 15(2):162. PubMed ID: 4844404
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.